1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
-
Mark
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
(
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
(
- Contribution to journal › Article
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
(
- Contribution to journal › Article
- 2019
-
Mark
Performance of gene expression-based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers : a case comparison study in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma
(
- Contribution to journal › Article
- 2017
-
Mark
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
(
- Contribution to journal › Article
-
Mark
Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
(
- Contribution to journal › Article
-
Mark
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
(
- Contribution to journal › Article